{"id":"berberine-placebo-tablets","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Berberine placebo tablets are inert tablets designed to match the appearance and administration schedule of active berberine formulations in randomized controlled trials. They serve as the control arm to assess the efficacy and safety of berberine by comparison against a non-therapeutic baseline. No pharmacological mechanism is present in the placebo itself.","oneSentence":"This is a placebo formulation containing no active pharmaceutical ingredient, used as a control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:22:17.950Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07356765","phase":"NA","title":"Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms","status":"ENROLLING_BY_INVITATION","sponsor":"Tianjin Anding Hospital","startDate":"2023-09-26","conditions":"Schizophrenia, Negative Symptoms of Schizophrenia","enrollment":120},{"nctId":"NCT07359209","phase":"NA","title":"Berberine Improving Cognitive Impairments in Schizophrenia","status":"ENROLLING_BY_INVITATION","sponsor":"Tianjin Anding Hospital","startDate":"2023-07-21","conditions":"Schizophrenia Therapeutics","enrollment":100},{"nctId":"NCT05720299","phase":"NA","title":"A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila and Berberine on Prediabetes Among Obese Subjects.","status":"COMPLETED","sponsor":"Yu Chen","startDate":"2025-03-12","conditions":"Prediabetes","enrollment":110},{"nctId":"NCT07129460","phase":"PHASE4","title":"Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia","status":"NOT_YET_RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2025-10-01","conditions":"Gastric Intestinal Metaplasia","enrollment":204},{"nctId":"NCT06782646","phase":"PHASE2, PHASE3","title":"Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine","status":"ENROLLING_BY_INVITATION","sponsor":"The University of Hong Kong","startDate":"2024-08-01","conditions":"Hyperlipidemia","enrollment":100},{"nctId":"NCT06629051","phase":"","title":"6-year Follow-up Data After the Berberine Intervention Trial","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-10-04","conditions":"Colorectal Adenoma, Colorectal Cancer Control and Prevention, Colorectal Polyps","enrollment":891},{"nctId":"NCT03198572","phase":"PHASE4","title":"Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2017-08-16","conditions":"Non-alcoholic Steatohepatitis","enrollment":120},{"nctId":"NCT03333265","phase":"PHASE2, PHASE3","title":"Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2017-09-01","conditions":"Colorectal Adenomas","enrollment":100},{"nctId":"NCT03281096","phase":"PHASE2, PHASE3","title":"A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2017-08-29","conditions":"Colorectal Adenomas","enrollment":1000},{"nctId":"NCT03388762","phase":"NA","title":"RCT of a Polyherbal Dietary Supplement for Prediabetes","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-05","conditions":"Prediabetic State","enrollment":39},{"nctId":"NCT04698330","phase":"PHASE4","title":"Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2022-05","conditions":"Type 1 Diabetes Mellitus, Autoimmune Diabetes","enrollment":240},{"nctId":"NCT05105321","phase":"PHASE4","title":"Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)","status":"NOT_YET_RECRUITING","sponsor":"Tang Yida","startDate":"2021-12","conditions":"Metabolic Syndrome","enrollment":5200},{"nctId":"NCT03330184","phase":"NA","title":"Effectiveness and Safety of Berberine Hydrochloride and Bifidobacterium in People With Abnormal Glucose Level","status":"COMPLETED","sponsor":"Xijing Hospital","startDate":"2015-10","conditions":"Berberine Hydrochloride","enrollment":300},{"nctId":"NCT02983188","phase":"PHASE2, PHASE3","title":"Berberine as Adjuvant Treatment for Schizophrenia Patients","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2018-04-25","conditions":"Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Metabolic Syndrome x","enrollment":113},{"nctId":"NCT03770325","phase":"PHASE2, PHASE3","title":"A Mechanistic Randomized Controlled Trial on the Cardiovascular Effect of Berberine","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2019-04-01","conditions":"Cardiovascular Risk Factor","enrollment":84},{"nctId":"NCT02861261","phase":"PHASE3","title":"A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2016-08-18","conditions":"Type 2 Diabetes","enrollment":400},{"nctId":"NCT02834078","phase":"NA","title":"Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome","status":"COMPLETED","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2015-09","conditions":"Pre Diabetes","enrollment":126},{"nctId":"NCT02295176","phase":"NA","title":"Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome","status":"COMPLETED","sponsor":"Rottapharm","startDate":"2013-04","conditions":"Metabolic Syndrome, Insulin-resistance, Left Ventricular Hypertrophy","enrollment":159},{"nctId":"NCT01116167","phase":"NA","title":"Polycystic Ovary Syndrome (PCOS): Effect Of Letrozole and Berberine","status":"UNKNOWN","sponsor":"Heilongjiang University of Chinese Medicine","startDate":"2009-10","conditions":"Polycystic Ovary Syndrome","enrollment":660},{"nctId":"NCT01562080","phase":"PHASE2, PHASE3","title":"Combined Effects of Bioactive Compounds in Lipid Profile","status":"COMPLETED","sponsor":"Rottapharm Spain","startDate":"2012-01","conditions":"Hyperlipidemia, Low-density-lipoprotein-type, Elevated Triglycerides","enrollment":118},{"nctId":"NCT01087632","phase":"NA","title":"Armolipid Plus and Metabolic Syndrome","status":"COMPLETED","sponsor":"Rottapharm","startDate":"2009-09","conditions":"Metabolic Syndrome","enrollment":66},{"nctId":"NCT00654459","phase":"","title":"Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function","status":"COMPLETED","sponsor":"Federico II University","startDate":"2007-07","conditions":"Hyperlipidemia, Endothelial Dysfunction","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Berberine placebo tablets","genericName":"Berberine placebo tablets","companyName":"Second Xiangya Hospital of Central South University","companyId":"second-xiangya-hospital-of-central-south-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}